Literature DB >> 20144376

Pilot evaluation of a prototype critical care blood glucose monitor in normal volunteers.

Marc C Torjman1, Michael E Goldberg, Jeffrey J Littman, Robert A Hirsh, Richard P Dellinger.   

Abstract

BACKGROUND: Availability of a highly accurate in-hospital automated blood glucose (BG) monitor could facilitate implementation of intensive insulin therapy protocols through effective titration of insulin therapy, improved BG control, and avoidance of hypoglycemia. We evaluated a functional prototype BG monitor designed to perform frequent automated blood sampling for glucose monitoring.
METHODS: Sixteen healthy adult volunteer subjects had intravenous catheter insertions in a forearm or hand vein and were studied for 8 hours. The prototype monitor consisted of an autosampling unit with a precise computer-controlled reversible syringe pump and a glucose analytical section. BG was referenced against a Yellow Springs Instrument (YSI) laboratory analyzer. Sampling errors for automated blood draws were assessed by calculating the percent of failed draws, and BG data were analyzed using the Bland and Altman technique.
RESULTS: Out of 498 total sample draws, unsuccessful draws were categorized as follow: 11 (2.2%) were due to autosampler technical problems, 21 (4.2%) were due to catheter-related failures, and 37 (7.4%) were BG meter errors confirmed by a glucometer-generated error code. Blood draw difficulties or failures related to the catheter site (e.g., catheter occlusion or vein collapse) occurred in 6/15 (40%) subjects. Mean BG bias versus YSI was 0.20 +/- 12.6 mg/dl, and mean absolute relative difference was 10.4%.
CONCLUSIONS: Automated phlebotomy can be performed in healthy subjects using this prototype BG monitor. The BG measurement technology had suboptimal accuracy based on a YSI reference. A more accurate BG point-of-care testing meter and strip technology have been incorporated into the future version of this monitor. Development of such a monitor could alleviate the burden of frequent BG testing and reduce the risk of hypoglycemia in patients on insulin therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20144376      PMCID: PMC2787022          DOI: 10.1177/193229680900300602

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  42 in total

1.  Blood glucose variability: a new paradigm in critical care?

Authors:  Alexandre Ouattara; André Grimaldi; Bruno Riou
Journal:  Anesthesiology       Date:  2006-08       Impact factor: 7.892

Review 2.  Tight blood glucose control with insulin in the ICU: facts and controversies.

Authors:  Ilse Vanhorebeek; Lies Langouche; Greet Van den Berghe
Journal:  Chest       Date:  2007-07       Impact factor: 9.410

3.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

Authors:  Etie S Moghissi; Mary T Korytkowski; Monica DiNardo; Daniel Einhorn; Richard Hellman; Irl B Hirsch; Silvio E Inzucchi; Faramarz Ismail-Beigi; M Sue Kirkman; Guillermo E Umpierrez
Journal:  Endocr Pract       Date:  2009 May-Jun       Impact factor: 3.443

4.  Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting.

Authors:  John Butterworth; Lynne E Wagenknecht; Claudine Legault; Daniel J Zaccaro; Neal D Kon; John W Hammon; Anne T Rogers; B Todd Troost; David A Stump; Curt D Furberg; Laura H Coker
Journal:  J Thorac Cardiovasc Surg       Date:  2005-11       Impact factor: 5.209

5.  Persistent hyperglycemia is predictive of outcome in critically ill trauma patients.

Authors:  Grant V Bochicchio; Jin Sung; Manjari Joshi; Kelly Bochicchio; Steven B Johnson; Walter Meyer; Thomas M Scalea
Journal:  J Trauma       Date:  2005-05

Review 6.  Should minimal blood glucose variability become the gold standard of glycemic control?

Authors:  Irl B Hirsch; Michael Brownlee
Journal:  J Diabetes Complications       Date:  2005 May-Jun       Impact factor: 2.852

7.  Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality.

Authors:  Jean-Claude Lacherade; Patricia Jabre; Sylvie Bastuji-Garin; David Grimaldi; Pascal Fangio; Valerie Théron; Hervé Outin; Bernard De Jonghe
Journal:  Intensive Care Med       Date:  2007-03-13       Impact factor: 17.440

8.  The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.

Authors: 
Journal:  Diabetes       Date:  1986-05       Impact factor: 9.461

9.  Blood glucose measurements in the critically ill: more than just a blood draw.

Authors:  Frank M Brunkhorst; Hans G Wahl
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  How to compare adequacy of algorithms to control blood glucose in the intensive care unit?

Authors:  Greet Van den Berghe
Journal:  Crit Care       Date:  2004-03-23       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.